查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1888545

美国乳癌诊断影像市场规模、份额和趋势分析报告：按技术、临床阶段、最终用途、地区和细分市场预测（2025-2033 年）

U.S. Breast Cancer Imaging Market Size, Share & Trends Analysis Report By Technology (Mammography System, Magnetic Resonance Imaging -based Systems), By Stage Of Care, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

美国乳癌诊断影像市场摘要

据估计，2024 年美国乳癌影像市场价值为 5.5788 亿美元，预计到 2033 年将达到 10.1217 亿美元。

预计2025年至2033年复合年增长率（CAGR）将达到7.42%。市场扩张的主要驱动因素是美国乳癌发生率的上升。根据Breastcancer.org网站报导，预计到2025年，美国将有约316,950名女性被诊断出患有侵袭性乳癌，此外还将新增59,080例导管原位癌（DCIS）病例，DCIS是一种非侵袭性乳癌。约16%的乳癌病例发生在50岁以下的女性。同一篇报导指出，乳癌是美国女性最常见的癌症，估计每8名女性中就有1名在一生中会被诊断出罹患乳癌。美国癌症协会表示，由于人口老化、生活方式改变和筛检技术的进步，乳癌的发生率逐年上升。高发病率和高死亡率推动了对乳房摄影影像服务（包括乳房X光检查、乳房MRI和数位乳房断层合成（DBT））的需求，从而推动了市场成长。

政府主导的旨在改善早期检测和诊断服务可近性的各项措施和筛检项目，显着扩大了美国乳癌诊断影像市场。为降低乳癌死亡率，美国预防服务工作小组（USPSTF）建议40至74岁的女性每两年进行一次乳房X光摄影检查。建立全国统一的筛检方案，确保更多女性能够及时获得诊断影像服务。此外，为支持早期检测和治疗，美国疾病管制与预防中心（CDC）的国家乳癌和子宫颈癌早期检测计画（NBCCEDP）为低收入和医疗服务不足的女性提供高品质的乳癌筛检和诊断服务。这些项目的数据表明，协调一致的筛检宣传活动能够改善患者预后，实现早期诊断，并促进患者坚持建议的影像检查计划。因此，政府推荐的筛检计画扩大了先进诊断影像技术（例如数位乳房摄影、乳房磁振造影和数位乳房断层合成（DBT））的普及范围，从而推动了美国乳癌诊断影像市场的成长。

诊断影像中心和诊断网路的扩张在美国乳癌诊断影像市场成长中发挥关键作用。诊断影像中心通常是门诊机构，可以是私人机构，也可以是医疗系统或医院运作的机构。这些机构配备放射科医生和内科医生，他们利用医学影像诊断和治疗疾病，确保对诊断测试结果进行专业解读。

根据 DEFINITIVE HETHCARE 截至 2025 年 1 月的最新数据，美国约有 15,000 家影像中心，为乳癌诊断服务提供了广泛的覆盖。中西部、东北部、西部和西南部的影像中心数量多于东南部。这种广泛的地理覆盖使患者能够更方便地获得乳房 X 光检查、乳房 MRI 和超音波等重要服务，同时也有助于早期发现患者并进行细胞监测。这些中心的成长和扩张凸显了扩展诊断网络的重要性，这有助于改善不同地区患者获得筛检和诊断服务的机会，并满足日益增长的乳癌诊断需求。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国乳癌诊断影像市场的变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 乳癌影像诊断市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
  • 乳癌影像诊断市场：检测数量
  • 乳癌诊断影像市场：平均检查价格

第四章美国乳癌诊断影像市场：技术预测与趋势分析

  • 乳癌诊断影像市场：技术波动分析
  • 乳癌影像诊断市场技术展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 乳房X光摄影系统（2D、3D）
  • 基于磁振造影（MRI）的系统
  • 基于核医学的系统
  • 基于超音波的系统
  • 其他的

第五章美国乳癌诊断影像市场：临床分期评估与趋势分析

  • 乳癌诊断影像市场：治疗阶段变化分析
  • 乳癌影像诊断市场：依治疗阶段展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 诊断
  • 预处理计划
  • 监测
  • 后续观察

第六章美国乳癌诊断影像市场：终端使用者估算与趋势分析

  • 乳癌诊断影像市场：最终用途差异分析
  • 乳癌诊断影像市场最终用途展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 医院
  • 诊断影像中心
  • 乳癌护理中心
  • 其他的

第七章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Holigic, Inc.
    • GE Healthcare
    • Siemens Healthineers
    • Seno Medical
    • b-rayZ
    • Analogic Corporation
    • Icad, Inc
    • Clairity, Inc.
    • Fujifilm
    • FONAR Corporation
Product Code: GVR-4-68040-791-1

U.S. Breast Cancer Imaging Market Summary

The U.S. breast cancer imaging market size was estimated at USD 557.88 million in 2024 and is expected to reach USD 1,012.17 million by 2033, growing at a CAGR of 7.42% from 2025 to 2033. A key factor driving market expansion is the rising prevalence of breast cancer in the country. According to Breastcancer.Org In the year 2025, approximately 316,950 women are predicted to be diagnosed with invasive breast cancer in the U.S, along with 59,080 new cases of ductal carcinoma in situ (DCIS), a non-invasive form of the disease. Furthermore, approximately 16% of breast cancer is diagnosed in women under age 50. The article states that breast cancer continues to be the most diagnosed cancer in U.S. women, with an estimated one in eight women expected to be diagnosed in their lifetime. According to American Cancer Society, the incidence has been on the rise through the years due to aging population, lifestyle opportunities, and improvements in detection. The high incidence rates, as well as high mortality rates, has fueled the demand for improving breast imaging services, including mammography, breast MRIs, and digital breast tomosynthesis (DBT), these factors are propelling growth in the market.

By enhancing early detection and access to diagnostic services, government initiatives and screening programs have significantly increased the market for breast cancer imaging in the U.S. In order to reduce the number of deaths from breast cancer, The U.S. Preventive Services Task Force (USPSTF) recommends that women aged 40 to 74 should undergo screening mammography every other year. By establishing uniform screening procedures nationwide, these recommendations ensure that more women receive imaging in a timely manner. In addition, to help with early detection and treatment, the U.S. Centers for Disease Control and Prevention (CDC)'s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-income and underserved women with high-quality breast cancer screening and diagnostic services. These programs' data demonstrate that organized screening campaigns improve patient outcomes, enable earlier diagnosis, and boost adherence to suggested imaging schedules, facilitates earlier diagnosis, and improves patient outcomes. Consequently, government-endorsed screening programs expand access to advanced imaging technologies such as digital mammography, breast MRI, and digital breast tomosynthesis (DBT), thereby driving growth in the U.S. Breast Cancer Imaging market.

The expansion of imaging centers and diagnostic networks is playing a crucial role in the growth of U.S. breast cancer imaging market. Typically, imaging centers are outpatient establishments; some are privately owned, while others are run by healthcare systems or hospitals. These facilities frequently employ radiologists and doctors who diagnose and treat diseases using medical imaging, guaranteeing skilled interpretation of diagnostic tests.

Recent data provided by DEFINITIVE HEALTHCARE as of January 2025 indicates that there are approximately 15,000 imaging centers in the U.S., allowing for widespread access to breast cancer diagnostic services. The Midwest, Northeast, West and Southwest have more imaging centers compared to the Southeast This widespread geographic coverage makes it easier for patients to access important services like mammography, breast MRI, and ultrasound. It also helps with early detection and cell monitoring of patients. The growth and expansion of these centers emphasize the importance of growing diagnostic networks, which improve access for patients in various regions to screening and diagnostic capabilities, and address the growing imaging needs for breast cancer.

U.S. Breast Cancer Imaging Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast cancer imaging market report based on technology, stage of care and end-use:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Mammography System (2D,3D)
  • Magnetic Resonance Imaging (MRI)-based systems
  • Nuclear Medicine- Based Systems
  • Ultrasound-Based Systems
  • Image-guided Biopsy
  • Others
  • Stage of Care Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics
  • Pre-treatment Planning
  • Monitoring
  • Surveillance (Follow-Up)
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Imaging Centers
  • Breast Care Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Stage of Care
    • 1.2.3. End-use
  • 1.3. Estimates and forecasts timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased database
    • 1.5.2. GVR's internal database
    • 1.5.3. Secondary sources
    • 1.5.4. Primary research
    • 1.5.5. Details of primary research
  • 1.6. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity flow analysis (Model 1)
    • 1.8.2. Approach 1: Commodity flow approach
    • 1.8.3. Volume price analysis (Model 2)
    • 1.8.4. Approach 2: Volume price analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology
    • 2.2.2. Stage of Care
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Cancer Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of breast cancer
      • 3.2.1.2. Government initiatives and screening programs
      • 3.2.1.3. Expansion of imaging centers
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Equipment Costs
      • 3.2.2.2. Maintenance costs
  • 3.3. Breast Cancer Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Breast Cancer Imaging Market: Number of Procedures
  • 3.5. Breast Cancer Imaging Market: Average Procedure Pricing

Chapter 4. U.S. Breast Cancer Imaging Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Breast Cancer Imaging Market: Technology Movement Analysis
  • 4.3. Breast Cancer Imaging Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Mammography System (2D,3D)
    • 4.5.1. Mammography System (2D,3D) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Magnetic Resonance Imaging (MRI)-based Systems
    • 4.6.1. Magnetic Resonance Imaging (MRI)-based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Nuclear Medicine- Based Systems
    • 4.7.1. Nuclear Medicine-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Ultrasound-Based Systems
    • 4.8.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Ultrasound-Based Systems
    • 4.9.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Cancer Imaging Market: Stage of Care Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Breast Cancer Imaging Market: Stage of Care Movement Analysis
  • 5.3. Breast Cancer Imaging Market by Stage of Care Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Pre-treatment Planning
    • 5.6.1. Pre-treatment Planning Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Monitoring
    • 5.7.1. Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Surveillance (Follow-Up)
    • 5.8.1. Surveillance (Follow-Up) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Cancer Imaging Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Breast Cancer Imaging Market: End-use Movement Analysis
  • 6.3. Breast Cancer Imaging Market by End-use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Diagnostic Imaging Centers
    • 6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Breast Care Centers
    • 6.7.1. Breast Care Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Holigic, Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. GE Healthcare
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Siemens Healthineers
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Seno Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. b-rayZ
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Analogic Corporation
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Icad, Inc
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Clairity, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Fujifilm
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. FONAR Corporation
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. Breast Cancer Imaging market, by technology specialty, (USD Million) 2021 - 2033
  • Table 4 U.S. Breast Cancer Imaging market, by stage of care, (USD Million) 2021 - 2033
  • Table 5 U.S. Breast Cancer Imaging market, by end-use, (USD Million) 2021 - 2033

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. Breast Cancer Imaging: market outlook
  • Fig. 9 U.S. Breast Cancer Imaging market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. Breast Cancer Imaging market driver impact
  • Fig. 15 U.S. Breast Cancer Imaging market restraint impact
  • Fig. 16 U.S. Breast Cancer Imaging market strategic initiatives analysis
  • Fig. 17 U.S. Breast Cancer Imaging market: technology movement analysis
  • Fig. 18 U.S. Breast Cancer Imaging market: technology outlook and key takeaways
  • Fig. 19 Mammography Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Magnetic Resonance Imaging (MRI)-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Nuclear Medicine-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Ultrasound-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 (USD Million)
  • Fig. 24 U.S. Breast Cancer Imaging market: stage of care movement analysis
  • Fig. 25 U.S. Breast Cancer Imaging market: stage of care outlook and key takeaways
  • Fig. 26 Diagnostic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Pre-treatment Planning market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Surveillance (Follow-Up) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Breast Cancer Imaging market, end- use outlook key takeaways (USD Million)
  • Fig. 31 Breast Cancer Imaging market end- use movement analysis (USD Million), 2024 & 2033
  • Fig. 32 Hospitals' market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Diagnostic Imaging Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Breast Care Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Participant categorization- U.S. Breast Cancer Imaging market
  • Fig. 37 Market share of key market players- U.S. Breast Cancer Imaging market